DNTH Dividend History & Analysis | 0% Yield
DNTH has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| ABBV | 389,032 M | 4.02% | 11.0% |
| GILD | 146,242 M | 2.93% | 5.88% |
| AMGN | 152,211 M | 3.35% | 4.44% |
| HLN | 44,172 M | 1.92% | 2.56% |
| BIOG-B | 1,118 M | 1.85% | 1.82% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BIOG-B | 1,118 M | 20.4% | 92.8% |
| GRFS | 8,687 M | 50.6% | 60.7% |
| SECARE | 679 M | 10.4% | 100% |
| AMGN | 152,211 M | 7.06% | 100% |
| ABBV | 389,032 M | 5.61% | 100% |
Similar Stocks with Attractive Dividends - Compare DNTH Dividends with its Peer-Group
4.02% Yield
3.35% Yield
2.93% Yield
1.78% Yield
DNTH Dividend History: as of September 2025
No dividends paid yet.DNTH Dividend FAQ
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is a clinical-stage biotech focused on complement-system therapeutics for severe autoimmune and inflammatory disorders. Its flagship candidate, DNTH-103, is a human IgG4 monoclonal antibody engineered to bind the active form of C1s with picomolar affinity. DNTH-103 is currently in Phase 2 trials for generalized myasthenia gravis (gMG), multifocal motor neuropathy (MMN), and chronic inflammatory demyelinating polyneuropathy (CIDP). The company was founded in 2019 and is headquartered in New York, New York.
What is the Dividend Yield of DNTH?
As of September 2025, DNTH`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 37.47.Does DNTH pay a dividend?
As of September 2025 DNTH does not pay a dividend.How often does DNTH pay dividends?
Over the last 12 months, DNTH has issued dividend payments.Will DNTH pay dividends in 2025?
The next Ex-Dividend date for Dianthus Therapeutics (DNTH) is currently unknown.What is the next Ex-Dividend Date for DNTH?
The next Ex-Dividend date for Dianthus Therapeutics (DNTH) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of DNTH?
DNTH's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of DNTH?
DNTH's 5-Year Yield on Cost is -%. If you bought DNTH's shares at 123.52 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of DNTH?
DNTH Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does DNTH have a good Dividend Yield?
DNTH`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of DNTH?
The Dividend Payout Ratio of DNTH is unknown.What is the Dividend Rating of DNTH?
DNTH`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-09-15 04:02